Troutman Pepper Hamilton Sanders advised Quercis Pharma on the deal. Quercis Pharma AG (“Quercis”), a private, clinical stage biopharmaceutical company, announced that it has signed a...
Quercis Pharma’s $150 Million Investment Commitment from GEM
PharmaCyte Biotech’s $15 Million Follow-On Public Offering
Troutman Pepper Hamilton Sanders advised PharmaCyte Biotech, Inc. on the deal. PharmaCyte Biotech, Inc. (NASDAQ: PMCB), a biotechnology company focused on developing cellular therapies for cancer...
PharmaCyte’s $70 Million Rights Offering
Troutman Pepper Hamilton Sanders advised PharmaCyte Biotech on the deal. PharmaCyte Biotech, Inc. (NASDAQ: PMCB), a biotechnology company focused on developing cellular therapies for cancer and...